Synergy Financial Group LTD Raises Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Synergy Financial Group LTD raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 32.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 993 shares of the biotechnology company’s stock after acquiring an additional 246 shares during the period. Synergy Financial Group LTD’s holdings in Axon Enterprise were worth $590,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of AXON. Groupama Asset Managment bought a new stake in Axon Enterprise during the 3rd quarter valued at $200,000. Massachusetts Financial Services Co. MA purchased a new stake in Axon Enterprise during the 3rd quarter worth about $120,553,000. Westfield Capital Management Co. LP boosted its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares during the period. Assenagon Asset Management S.A. boosted its stake in Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after purchasing an additional 111,405 shares during the period. Finally, Champlain Investment Partners LLC grew its holdings in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on AXON. Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price for the company. in a research report on Thursday, February 20th. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $561.31.

Insider Buying and Selling

In other news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock valued at $5,631,561 over the last ninety days. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

AXON stock opened at $499.73 on Tuesday. The firm has a 50-day moving average of $616.95 and a 200 day moving average of $520.78. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $38.10 billion, a P/E ratio of 129.13, a PEG ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.